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SUMMARY 
 
CXCR4 expression was analysed on feline peripheral blood mononuclear cells (PBMC). 
While monocytes and B lymphocytes expressed CXCR4, no CXCR4 was detected on T 
lymphocytes, in stark contrast to the expression pattern on T lymphocytes from human 
beings.  In spite of the important role that CXCR4 plays in infection with feline 
immunodeficiency virus (FIV), expression on PBMC in vivo was unaffected by infection 
with either primary or cell culture-adapted strains of virus.    
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The major pathway of infection with the primate lentiviruses involves attachment 
of the virus via a high affinity interaction with CD4 followed by binding to a seven 
transmembrane domain molecule (7TM), principally CXCR4 or CCR5.  Consequently, 
viruses that utilize CXCR4 as a receptor target preferentially the cell types expressing 
CXCR4 while those using CCR5 target CCR5-expressing cells.  In human beings, the 
expression of CCR5 on peripheral blood T cells is restricted largely to CD4+/CD45RO+ 
cells (memory cells), while CXCR4 is expressed on both naïve and memory T cells, 
albeit with higher levels on CD4+/CD45RA+ cells (naïve cells) (3, 13, 14, 16, 18). 
Moreover, CXCR4 expression is not restricted to T cells; significant amounts of CXCR4 
are found on B cells while NK cells are effectively negative for expression (3, 13). 
Conversely, CCR5  is expressed on NK cells and not B cells. The differential expression 
of CXCR4 and CCR5 in the immune system of human beings  may provide a basis for 
the specific targeting of memory T cells early in infection (when CCR5-dependent strains 
predominate) and the wider range of cell types targeted with the emergence of CXCR4-
dependent strains in the later stages of infection (3, 23).  Previous studies demonstrated 
that feline immunodeficiency virus (FIV) utilised the feline homologue of CXCR4 as a 
receptor (21, 22).  The envelope glycoprotein from cell culture-adapted strains of FIV 
binds with a high affinity to CXCR4-expressing cells (11) and infection with both cell 
culture-adapted and primary strains of FIV is blocked by CXCR4 antagonists (9-11, 17, 
19).   Given the restricted expression of CXCR4 and CCR5 in the immune system of 
human beings, and how this affects the in vivo tropism of HIV, it is important to 
determine the expression pattern of CXCR4 in the domestic cat in order to elucidate the 
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in vivo cell tropism of FIV and ultimately the pathogenesis of  FIV-related 
immunodeficiency. 
CXCR4 expression in vivo. Using a cross-species reactive anti-human CXCR4 
monoclonal antibodies (44701, 44717 and 44718, provided by M. Tsang, R&D Systems, 
Minneapolis) that we identified previously (11), we applied two-colour flow cytometry to 
examine CXCR4 expression on feline peripheral blood mononuclear cells (Fig. 1).  
Feline leucocytes were prepared by whole blood lysis (20) and analysed on an EPICS 
Elite flow cytometer (Beckman Coulter, Sheffield, UK).  Lymphocyte, monocytes and 
granulocyte populations were identified on the basis of their forward scatter (FSC) vs. 90o 
side scatter (SSC) characteristics (Fig. 1a). CXCR4 expression resided largely within the 
lymphoid gate (L) with a distinct population clustering in the region (M) consisting 
predominantly of monocytes (Fig. 1b).  In order to confirm the identity of the monocyte 
population, the cells were dual-labelled with antibodies recognizing CXCR4 (44718) and 
CD14 (Tük 4, Dako Ltd., Ely, UK), a marker expressed at high levels on both murine and 
human monocytes but also to a lesser degree on a subpopulation of human B cells  (12).  
CD14 expression resided largely within the expected monocyte gate (Fig. 1c) with a 
minor population of lymphocytes expressing CD14, consistent with feline CD14 having a 
similar expression pattern to human CD14.  To further confirm the validity of the 
monocyte gate, a parallel sample was stained with the B cell marker, B220 (CD45R, 
Beckton Dickinson UK Ltd., Cowley, UK). Expression of B220 was restricted 
predominantly to the lymphoid gate (Fig. 1d) and did not correlate with the monocyte 
population identified by CD14 expression. Thus monocytes could be reliably identified 
on the basis of FSC versus SSC characteristics (monocyte (M) gate, Fig. 1a.) in 
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conjunction with CD14 expression.  The expression of CXCR4 on CD14+ monocytes 
was variable, however, expression was detected consistently on monocytes from all cats 
tested (Fig. 1e).  We examined next the expression of CXCR4 on lymphoid cells. The 
majority of CXCR4 expression resided in the B220+ population (B cells, Fig. 1f).  While 
the intensity of CXCR4 expression varied amongst cats, the level of expression was 
consistent amongst analyses. CD5+ lymphocytes (in the domestic cat, CD5 expression is 
restricted to T cells (1, 4)) were ostensibly negative for CXCR4 (Fig. 1g).  Similar 
findings were obtained using antibodies against feline CD4, CD8 and CD3 (data not 
shown).  Anti-CXCR4 antibodies 44701 and 44717 (R&D Systems) yielded similar 
findings to antibody 44718 (data not shown) suggesting that the low level of reactivity 
with feline T cells is unlikely to result from the expression of a distinct antigenic 
conformation of CXCR4 on these cells. In order to compare the intensity of CXCR4 
expression on feline and human lymphocytes we processed samples of feline and human 
blood in parallel for flow cytometry (Fig. 2). While CXCR4 expression was detected on 
both feline (Fig. 2b, B220+) and human (Fig. 2e, CD19+) B cells, only human T cells 
(Fig. 2f, CD3+) but not feline T cells (Fig. 2c, CD5+) expressed detectable levels of 
CXCR4.  Although human lymphocytes (Fig. 2d.) were observed to be larger than feline 
lymphocytes (Fig. 2a.), the smaller surface area of the feline cells was insufficient to 
account for the failure to detect CXCR4 expression on feline T cells. Thus while 
expression of CXCR4 on both B cells and monocytes in the cat is similar to the 
expression pattern in human beings, it differs markedly in that it is undetectable on 
peripheral T cells. It is intriguing that the human and feline viruses induce such similar 
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disease conditions while the major (co)receptor distribution varies between the two 
species. 
  CXCR4 expression in FIV-infected cats. CXCR4 expression is down-
modulated on some T cell subsets from HIV-infected human beings (15). Given that 
CXCR4 expression is down-regulated on FIV infected cells in vitro  (11), we asked 
whether FIV infection affected CXCR4 expression in vivo.  The expression of  CXCR4 
was examined in three groups of three age-matched animals that were either uninfected 
(control), or had been infected for two years with either a primary strain of FIV (GL8414) 
or a cell-culture adapted strain of FIV (PETF14). Mean CXCR4 expression (absolute 
number or fluorescence intensity) was remarkably consistent amongst the three study 
groups (Table 1 , Group 1), although a wide range of values was observed, in agreement 
with chemokine receptor expression on human PBMC (13).  Further, CXCR4 expression 
was consistent amongst three separate analyses (data not shown).  Given that it was not 
possible to analyse CXCR4 expression prior to infection in these animals, we monitored 
CXCR4 expression on T and B cells in a second group of 4 cats (vaccine study control 
group) during the early phase of infection with GL8414. CXCR4 expression was analysed 
at 1 week prior to challenge, and at 2, 6 and 13 weeks post-infection (Table 1, Group 2). 
CXCR4 expression did not differ significantly on CD5+ T cells or B220+ B cells during 
the course of the analyses.  Taken together, the data indicate that FIV infection does not 
induce gross alterations in the level of CXCR4 expression on feline PBMC. 
Infection with FIV is CXCR4-dependent (9, 11, 17, 22),  thus the expression of 
CXCR4 on feline monocytes is consistent with FIV being a monocyte-tropic virus (8). 
Similarly, the high level of CXCR4 expression on B cells is consistent with B cells being 
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a major reservoir for proviral DNA in chronic infection (5). However, the failure to detect 
CXCR4 expression on the majority of T lymphocytes in peripheral blood is in contrast to 
the distribution of CXCR4 expression in human beings (3, 13). While it is possible that 
CXCR4 may be expressed on resting feline T cells in an antigenic conformation that is 
not recognized by the CXCR4 antibodies used in this study, previous data have 
demonstrated that the same anti-CXCR4 antibodies used in this study (44701, 44717 and 
44718) recognize human CXCR4 on both T and B cells (2) and feline CXCR4 on a range 
of cell types (11). Moreover, using the same antibodies, we were able to detect CXCR4 
expression on freshly isolated feline thymocytes and on a proportion of T cells within 
lymph nodes (data not shown), in support of a previous study showing CXCR4 
expression on mitogen- activated feline T cells (17).  It was shown recently that HIV-
specific CD4+ T cells are infected preferentially by HIV in vivo  (7) and given that the 
major reservoir for FIV in early infection is CD4+ lymphocytes, it is possible that in the 
early stages of infection, FIV infection is restricted to activated T cells within the 
lymphatic system.  Thus, if the majority of CXCR4-expressing T cells within the lymph 
node are CD4+, then CD4+ T cells would be targeted selectively in early infection. 
Alternatively, early infection may require an interaction with either a non-CXCR4 
receptor (6), or a primary receptor in addition to CXCR4,  the expression of which is 
restricted to activated CD4+ lymphocytes. Further elucidation of the mechanism of FIV 
infection in vivo may reveal conservation of important host and viral factors between this 
animal lentivirus and its human counterpart. 
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FIGURE LEGENDS 
 
Figure 1.  CXCR4 expression on feline peripheral blood mononuclear cells. A. 
Discrimination of lymphocytes (L), monocytes (M) and granulocytes (G) by forward 
scatter (FSC) vs.  90oC side scatter (SSC).  CXCR4+ (B), CD14+ (C) and B220+ (D) 
cells back-gated on a plot of FSC vs. SSC.  Two colour analysis of CXCR4 expression 
(phycoerythrin, PE) vs. CD14 (E), B220 (F) or CD5 (G) coupled to fluorescein 
isothiocyanate (FITC). Each figure represents 10,000 events, data analysis used Expo 
ADC software (Applied Cytometry Systems, Sheffield, U.K.). 
 
Figure 2. Comparison of CXCR4 expression on feline and human T cells. Feline PBMC 
and human PBMC were processed for flow cytometry by whole blood lysis. 
Lymphocytes were identified on the basis of forward scatter (FSC) vs.  90oC side scatter 
(SSC) characteristics (dotted lines illustrate the respective sizes of feline (A) and human 
(D) lymphocytes, ellipse delineates the analysis gate). Two colour analysis of CXCR4 
expression (PE) vs. B220 (B) and CD5 (C) on feline lymphocytes and CD19 (E) and CD3 
(F) on human lymphocytes.  Each figure represents 10,000 events, data are presented 
without baseline offset. 
 
 
 
CXCR4 expression in the cat 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
L
M
G
FS
C
SSC
A B C
CD14CXCR4
B220 - FITC CD5 - FITC
C
X
C
R
4
 -
P
E
CD14 - FITC
CD14 +CXCR4+
E F G
B220
D
FS
C
C
X
C
R
4
 -
P
E
CXCR4 expression in the cat 
 
 
B C
E FD
A
SSC
SSC
FS
C
FS
C
C
X
C
R
4
-P
E
C
X
C
R
4
-P
E
C
X
C
R
4
-P
E
C
X
C
R
4
-P
E
B220-FITC
CD19-FITC
CD5-FITC
CD3-FITC
FS
C
FS
C
C
X
C
R
4
-P
E
C
X
C
R
4
-P
E
C
X
C
R
4
-P
E
C
X
C
R
4
-P
E
CXCR4 expression in the cat 
REFERENCES 
 
1. Ackley, C. D. and M. D. Cooper. 1992. Characterization of a feline T-cell-specific 
monoclonal antibody reactive with a CD5-like molecule. Am. J. Vet. Res. 53:466-471. 
2. Baribaud, F., T. G. Edwards, M. Sharron, A. Brelot, N. Heveker, K. Price, F. 
Mortari, M. Alizon, M. Tsang, and R. W. Doms . 2001. Antigenically distinct 
conformations of CXCR4. J. Virol. 75:8957-8967. 
3. Bleul, C. C., L. J. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The 
HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human 
T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925-1930. 
4. Brown, A. L., T. H. Dunsford, O. Jarrett, B. J. Willett, and M. J. Hosie. 2002. 
Demonstration of biological activity of CD40 ligand (CD154) in the domestic cat. 
Cytokine 17:140-148. 
5. Dean, G. A., G. H. Reubel, P. F. Moore, and N. C. Pedersen. 1996. Proviral burden 
and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood 
and lymph node. J. Virol. 70:5165-5169. 
6. deParseval, A. and J. H. Elder. 2001. Binding of recombinant feline 
immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface 
heparans, and an unidentified non-CXCR4 receptor. J. Virol. 75:4528-4539. 
7. Douek, D. C., J. M. Brenchley, M. R. Betts, D. R. Ambrozak, B. J. Hill, Y. 
Okamoto, J. P. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, Z. Grossman, M. 
Dybul, A. Oxenius, D. A. Price, M. Connors, and R. A. Koup. 2002. HIV 
preferentially infects HIV-specific CD4+ T cells. Nature 417:95-98. 
8. Dow, S. W., C. K. Mathiason, and E. A. Hoover. 1999. In vivo monocyte tropism of 
pathogenic feline immunodeficiency viruses. J. Virol. 73:6852-6861. 
CXCR4 expression in the cat 
9. Egberink, H. F., E. De Clerq, A. L. Van Vliet, J. Balzarini, G. J. Bridger, G. 
Henson, M. C. Horzinek, and D. Schols. 1999. Bicyclams, selective antagonists of the 
human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus 
replication. J. Virol. 73:6346-6352. 
10. Endo, Y., Y. Goto, Y. Nishimura, T. Mizuno, T. Watari, A. Hasegawa, T. 
Hohdatsu, H. Koyama, and H. Tsujimoto. 2000. Inhibitory effect of stromal cell 
derived factor-1 on the replication of divergent strains of feline immunodeficiency virus 
in a feline T-lymphoid cell line. Vet. Immunol. Immunopathol. 74:303-314. 
11. Hosie, M. J., N. Broere, J. Hesselgesser, J. D. Turner, J. A. Hoxie, J. C. Neil, and 
B. J. Willett. 1998. Modulation of feline immunodeficiency virus infection by stromal 
cell-derived factor (SDF-1). J. Virol. 72:2097-2104. 
12. Labeta, M. O., R. Landmann, J. P. Obrecht, and R. Obrist. 1991. Human B cells 
express membrane-bound and soluble forms of the CD14 myeloid antigen. Mol. 
Immunol. 28:115-122. 
13. Lee, B., M. Sharron, L. J. Montaner, D. Weissman, and R. W. Doms. 1999. 
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, 
and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. U. 
S. A. 96:5215-5220. 
14. Mackay, C. R. 1999. Dual personality of memory T cells. Nature 401:659-660. 
15. Nicholson, J. K., S. W. Browning, R. L. Hengel, E. Lew, L. E. Gallagher, D. 
Rimland, and J. S. McDougal. 2001. CCR5 and CXCR4 expression on memory and 
naive T cells in HIV-1 infection and response to highly active antiretroviral therapy. J. 
Acquir. Immune. Defic. Syndr. 27:105-115. 
16. Qin, S., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. 
Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 
CXCR4 expression in the cat 
mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest 
101:746-754. 
17. Richardson, J., G. Pancino, T. Leste-Lasserre, J. Schneider-Mergener, M. 
Alizon, P. Sonigo, and N. Heveker. 1999. Shared usage of the chemokine receptor 
CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J. 
Virol. 73:3661-3671. 
18. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible 
programs of chemokine receptor expression on human polarized T helper 1 and 2 
lymphocytes. J. Exp. Med. 187:875-883. 
19. Willett, B. J. and M. J. Hosie. 1999. The role of the chemokine receptor CXCR4 in 
infection with feline immunodeficiency virus. Molecular Membrane Biology 16:67-72. 
20. Willett, B. J., M. J. Hosie, J. J. Callanan, J. C. Neil, and O. Jarrett. 1993. 
Infection with feline immunodeficiency virus is followed by the rapid expansion of a 
CD8+ lymphocyte subset. Immunology 78:1-6. 
21. Willett, B. J., M. J. Hosie, J. C. Neil, J. D. Turner, and J. A. Hoxie. 1997. 
Common mechanism of infection by lentiviruses. Nature 385:587. 
22. Willett, B. J., L. Picard, M. J. Hosie, J. D. Turner, K. Adema, and P. R. 
Clapham. 1997. Shared usage of the chemokine receptor CXCR4 by the feline and 
human  immunodeficiency viruses. J. Virol. 71:6407-6415. 
23. Wu, L. J., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. 
Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. Mackay. 1997. CCR5 levels 
and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. 
J. Exp. Med. 185:1681-1691. 
 
